Effects of environmental tobacco smoke exposure on pulmonary immune response in infant monkeys

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 2, 2008, Pages

  Wang, Lei ^a   Joad, Jesse P ^b   Zhong, Caiyun ^a   Pinkerton, Kent E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Environmental tobacco smoke; lung development; TH1 immune response

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; MESSENGER RNA; MONOKINE; PROTEIN P70; TOBACCO SMOKE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; FEMALE; IMMUNE RESPONSE; IMMUNITY; LUNG; LUNG DEVELOPMENT; MONKEY; NONHUMAN; PERINATAL PERIOD; PRIMATE; PRIORITY JOURNAL; THYMUS;

EID: 48349139333     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.04.011     Document Type: Article

References (53)

1. Gleeson M., and Cripps A.W. Development of mucosal immunity in the first year of life and relationship to sudden infant death syndrome. FEMS Immunol Med Microbiol 42 (2004) 21-33
2. Pinkerton K.E., and Joad J.P. Influence of air pollution on respiratory health during perinatal development. Clin Exp Pharmacol Physiol 33 (2006) 269-272
3. Kraemer M.J., Richardson M.A., Weiss N.S., Furukawa C.T., Shapiro G.G., Pierson W.E., et al. Risk factors for persistent middle-ear effusions: otitis media, catarrh, cigarette smoke exposure and atopy. JAMA 249 (1983) 1022-1025
4. Gortmaker S.L., Walker D.K., Jacobs F.H., and Ruch-Ross H. Parental smoking and the risk of childhood asthma. Am J Public Health 72 (1982) 574-579
5. Pedreira F.A., Guandolo V.L., Feroli E.J., Mella G.W., and Weiss I.P. Involuntary smoking and incidence of respiratory illness during the first year of life. Pediatrics 75 (1985) 594-597
6. Smit J.J., and Lukacs N.W. A closer look at chemokines and their role in asthmatic responses. Eur J Pharmacol 533 (2006) 277-288
7. Glimcher L.H., and Murphy K.M. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 14 (2000) 1693-1711
8. Chtanova T., Kemp R.A., Sutherland A.P.R., Ronchese F., and Mackay C.R. Gene microarrays reveal extensive differential gene expression in both CD4+ and CD8+ type 1 and type 2 T cells. J Immunol 167 (2001) 3057-3063
9. Sallusto F., Lenig D., Mackay C.R., and Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187 (1998) 875-883
10. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 helper cells (Th1s) and Th2s. J Exp Med 187 (1998) 129-134
11. Robinson D.S., and Lloyd C.M. Asthma: T-bet: a master controller?. Curr Biol 12 (2002) R322-R324
12. Adkins B., Bu Y., and Guevara P. The generation of Th memory in neonates versus adults: prolonged primary Th2 effector function and impaired development of Th1 memory effector function in murine neonates. J Immunol 166 (2001) 918-925
13. Wilson C.B., Westall J., Johnston L., Lewis D.B., Dower S.K., and Alpert A.R. Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest 77 (1986) 860-867
14. Peden D.B. Development of atopy and asthma: candidate environmental influences and important periods of exposure. Environ Health Prospect 108 suppl 3 (2000) 475-482
15. Vassallo R., Tamada K., Lau J.S., Kroening P.R., and Chen L. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 175 (2005) 2684-2691
16. Kim E., Kang B.Y., and Kim T.S. Inhibition of interleukin-12 production in mouse macrophages by hydroquinone, a reactive metabolite of benzene, via suppression of nuclear factor-kappaB binding activity. Immunol Lett 99 (2005) 24-29
17. Ritter M., Goggel R., Chaudhary N., Wiedenmann A., Jung B., Weith A., et al. Elevated expression of TARC (CCL17) and MDC (CCL22) in models of cigarette smoke-induced pulmonary inflammation. Biochem Biophys Res Commun 334 (2005) 254-262
18. Seymour B.W., Pinkerton K.E., Friebertshauser K.E., Coffman R.L., and Gershwin L.J. Second-hand smoke is an adjuvant for T helper-2 responses in a murine model of allergy. J Immunol 159 (1997) 6169-6175
19. Wang L., Joad J.P., Abel K., Spinner A., Smiley-Jewell S., Liu H., and Pinkerton K.E. Effects of environmental tobacco smoke on the developing immune system of infant monkeys. J Allergy Clin Immunol 120 (2007) 445-451
20. Teague S.V., Pinkerton K.E., Goldsmith M., Gebremichael A., Chang S., Jenkins R.A., et al. A sidestream cigarette smoke generation and exposure system for environmental tobacco smoke studies. Inhal Toxicol 6 (1994) 79-93
21. Vogel C.F., Zhao Y., Wong P., Young N.F., and Matsumura F. The use of c-src knockout mice for the identification of the main toxic signaling pathway of TCDD to induce wasting syndrome. J Biochem Mol Toxicol 17 (2003) 305-315
22. Murphy P.M. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 54 (2002) 227-229
23. Mosmann T., and Coffman R. TH1 and TH2: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173
24. Munk M.E., and Emoto M. Functions of T-cell subsets and cytokines in mycobacterial infections. Eur Respir J Suppl 20 (1995) 668s-675s
25. Jacobs M., Brown N., Allie N., Gulert R., and Ryffel B. Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology 100 (2000) 494-501
26. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., and Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259 (1993) 1739-1742
27. Rabin R.L., Park M.K., Liao F., Swofford R., Stephany D., and Farber J.M. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J Immunol 162 (1999) 3840-3850
28. Weng Y., Siciliano S.J., Waldburger K.E., Sirotina-Meisher A., Staruch M.J., Daugherty B.L., et al. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem 273 (1998) 18288-18291
29. Cole K.E., Strick C.A., Paradis T.J., Ogborne K.T., Loetscher M., Gladue R.P., et al. Interferon inducible T cell α chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187 (1998) 2009-2021
30. Lu B., Humbles A., Bota D., Gerard C., Moser B., Soler D., et al. Structure and function of the murine chemokine receptor CXCR3. Eur J Immunol 29 (1999) 3804-3812
31. Luster A.D., and Ravetch J.V. Biochemical characterization of a γ interferon-inducible cytokine (IP-10). J Exp Med 166 (1987) 1084-1097
32. Farber J.M. A macrophage mRNA selectively induced by γ-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci U S A 87 (1990) 5238-5242
33. Farber J.M. MIG and IP-10: CXC chemokines that target lymphocytes. J Leukocyte Biol 61 (1997) 246-257
34. Zhao D.X., Hu Y., Miller G.G., Luster A.D., Mitchell R.N., and Libby P. Differential expression of the IFN-γ-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell αchemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J Immunol 169 (2002) 1556-1560
35. O'Garra A. Commitment factors for T helper cells. Curr Biol 10 (2000) R492-R494
36. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Ann Rev Immunol 17 (1999) 255-281
37. Kapsenberg M.L., Hilkens C.M.U., Wierenga E.A., and Kalinski P. The paradigm of type 1 and type 2 antigen-presenting cells. Clin Exp Allergy 29 suppl 2 (1999) 33-36
38. Trinchieri G. Interleukin-12: a cytokine produced by antigen presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84 (1994) 4008-4027
39. van der Pouw Kraan T.C., Boeije L.C., de Groot E.R., Stapel S.O., Snijders A., Kapsenberg M.L., et al. Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma. J Immunol 158 (1997) 5560-5565
40. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174 (1991) 1209-1220
41. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
42. Phaybouth V., Wang S.Z., Hutt J.A., McDonald J.D., Harrod K.S., and Barrett E.G. Cigarette smoke suppresses Th1 cytokine production and increases RSV expression in a neonatal model. Am J Physiol Lung Cell Mol Physiol 290 (2006) L222-L231
43. van der Pouw Kraan T.C., Boeije L.C., Smeenk R.J., Wijdenes J., and Aarden L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med 181 (1995) 775-779
44. Lambert C., Li J., Jonscher K., Yang T.C., Reigan P., Quintana M., et al. Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-{kappa}B1 DNA binding domain. J Biol Chem 282 (2007) 19666-19675
45. Leem J.H., Kim J.H., Lee K.H., Hong Y., Lee K.H., Kang D., et al. Asthma attack associated with oxidative stress by exposure to ETS and PAH. J Asthma 42 (2005) 463-467
46. Bardelli C., Gunella G., Varsaldi F., Balbo P., Del Boca E., Bernardone I.S., et al. Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway. Br J Pharmacol 145 (2005) 385-396
47. Bonfield T.L., Konstan M.W., and Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 104 (1999) 72-78
48. Neurath M.F., Weigmann B., Finotto S., Glickman J., Nieuwenhuis E., Iijima H., et al. The transcription factor Tbet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 195 (2002) 1129-1143
49. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman CG., and Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 (2000) 655-669
50. Farrar J.D., Ouyang W., Löhning M., Assenmacher M., Radbruch A., Kanagawa O., et al. An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3. J Exp Med 193 (2001) 643-650
51. Zhang D.H., Cohn L., Ray P., Bottomly K., and Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2- specific expression of the interleukin-5 gene. J Biol Chem 272 (1997) 21597-21603
52. Kishikawa H., Sun J., Choi A., Miaw S.C., and Ho I.C. The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J Immunol 167 (2001) 4414-4420
53. Ko F.W., Lun S.W., Wong C.K., Szeto C.C., Lam C.W., Leung T.F., et al. Decreased T-bet expression and changes in chemokine levels in adults with asthma. Clin Exp Immunol 147 (2007) 526-532